Wire · technology
'The best is yet to come': Bayer doubles down on US with plans for $2.2B Ohio manufacturing site
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 2 October 2026 · Fusion42 review
Bayer plans to invest $2.2 billion in a new high-tech manufacturing campus in New Albany, Ohio, which will open in phases from 2031 and create 600 full-time jobs. This expansion supports Bayer's strategy to grow its U.S. pharmaceutical operations, emphasizing resilient supply chains and proximity to major markets.
This Wire brief sits within Fusion42's coverage of Biotech.
◆ ◆ The Wire takeaway
You can expect U.S.-based pharma manufacturing to become a stronger growth lever as Bayer bet big on Ohio. Founders in drug production and automation should explore partnerships or supply opportunities around this new high-tech site.
◆ Coverage
1 source · 2 Oct 2026
◆ Related on Wire
◆ Topics